Answers are grounded in this paper and cite their sources.
Review highlights epigenetic changes influencing immune response and β-cell function in type 1 diabetes, suggesting new therapy avenues.
Epigenetic changes form a critical link between genetics, environment, and immune dysfunction in T1DM. By regulating immune responses and β-cell integrity, they drive disease onset and progression. Their study provides opportunities for predictive biomarkers and innovative therapies aimed at reprogramming epigenetic pathways to restore immune tolerance and preserve β-cell function.
No takes yet. Share an insight, caveat, or question.
Azevedo et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: